News & Updates

June 19, 2019

A new study in the Journal of Viral Hepatitis found that magnetic resonance elastography (MRE) had much higher accuracy than serum-based markers for predicting risk of hepatocellular carcinoma (HCC) development after sustained virological response (SVR) for Hepatitis C treatment.  Monitoring patients for subsequent development of HCC is clinically important, and the usefulness of noninvasive markers for prediction HCC has long been of interest to clinicians and researchers.

"This important study demonstrates the clinical utility of MRE for patients who receive direct acting antiviral (DAA) treatment for Hepatitis C," said Richard Ehman, MD, Ma...

June 12, 2019

During International NASH Day 2019, Resoundant is proud to join the Global Liver Institute (GLI) and many other dedicated clinicians and patients in raising awareness of this life threatening condition.

Non-alcoholic steatohepatitis, or NASH, has been called an epidemic, a "ticking time bomb", and a "silent tsunami". It is the progressive form of non-alcoholic fatty liver disease (NAFLD), and affects more than 115 million people worldwide. An estimated 357 million people will be affected by 2030.

Because NASH symptoms are not overt, NASH is often underdiagnosed and underreported. NAFLD and NASH are major risk factors for other health conditions: more than 70% of patien...

May 21, 2019

Supported by the European Union with 34 million euro as part of the European Innovative Medicines Initiative, the LITMUS (Liver Investigation: Testing Marker Utility in Steatohepatitis) project brings together clinicians and scientists to develop new non-invasive diagnostic tests to assess patients with non-alcoholic fatty liver disease (NAFLD).

The LITMUS project will run for 5 years, involving over 90 academic centers and companies across Europe and the US, and is coordinated by the University of Newcastle, in collaboration with Pfizer Ltd.

"Resoundant looks forward to participating in this ground-breaking, multi-stakeholder project to help address one medicine’s...

Please reload

Search News
Please reload

RSS Feed

+1 507-322-0011

© 2020 by Resoundant, Inc.

421 1st Ave SW STE 204W

Rochester, MN

55902, United States

  • Black Facebook Icon
  • Black Twitter Icon
  • Black LinkedIn Icon